ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease and rheumatoid arthritis (RA)"

  • Abstract Number: 2131 • 2015 ACR/ARHP Annual Meeting

    Younger Age and Female Gender Are the Main Determinants of Underestimation of Cardiovascular Risk in Rheumatoid Arthritis Patients

    Calin Popa1,2, Alexander Rennings3, Alfons A. den Broeder4, Frank H.J. van den Hoogen4, Inger L. Meek1 and Jaap Fransen1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Bernhoven Hospital, Uden, Netherlands, 3Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients have an increased cardiovascular (CV) risk. Current algorithms generally underestimate the risk in these patients [1]. In a meta-analysis, we…
  • Abstract Number: 1501 • 2015 ACR/ARHP Annual Meeting

    Prevalence of Unassessed and Uncontrolled Cardiovascular Disease Risk Factors Among Rheumatoid Arthritis Patients in an Academic Rheumatology Practice

    Darcy S. Majka1, Eric M. Ruderman2, Ji Young Lee3, Elisha Friesema4 and Stephen D. Persell4, 1Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL, 4General Internal Medicine, Northwestern University Feinberg School of Medicine, chicago, IL

    Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death in individuals with rheumatoid arthritis (RA). Patients with RA are at 1.5-2.0-fold increased risk of…
  • Abstract Number: 2630 • 2015 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up

    Raymundo Vera-Pineda1, Alberto Cardenas-de La Garza2, Dionicio A. Galarza-Delgado2, Jose Ramon Azpiri-Lopez3, Iris J. Colunga-Pedraza2, Jorge Munoz De Hoyos2, Griselda Serna-Peña4, Brenda B Tovar-Jasso2, Mario Alberto Garza-Elizondo2 and Gerardo Ornelas5, 1Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 2Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 3Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 4Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico, 5Radiology, Hospital Universitario, UANL., Monterrey, Mexico

    Background/Purpose: The main cause of mortality in patients with rheumatoid arthritis (RA) is atherosclerotic cardiovascular disease (ASCVD). RA patients have a 10-year decrease in life…
  • Abstract Number: 1540 • 2015 ACR/ARHP Annual Meeting

    Cardiovascular Risk Management in Rheumatoid Arthritis Patients

    Calin Popa1, Elke.E.A. Arts1, Inger L. Meek1, Frank H.J. van den Hoogen2 and Jaap Fransen1, 1Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients have been previously shown to have a higher cardiovascular (CV) burden as compared to the general population. The CV risk…
  • Abstract Number: 2636 • 2015 ACR/ARHP Annual Meeting

    Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-Based Cohort

    Caroline Ball1, John M. Davis III2, Cynthia S. Crowson3, Iftikhar Kullo4, Eric L. Matteson5 and Rekha Mankad6, 1Internal Medicine, Mayo Clinic, Rochester, MN, 2Division of Rheumatology, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 6Cardiovascular Diseases, Mayo Clinic, Rochester, MN

    Title: Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-based Cohort Background/Purpose: Patients with rheumatoid arthritis (RA) have increased risk of cardiovascular…
  • Abstract Number: 1542 • 2015 ACR/ARHP Annual Meeting

    Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis

    Ariana González-Meléndez1, Ruth Fred-Jimenez2, Mariangelí Arroyo-Ávila2, Leyda Díaz-Correa2, Naydi Pérez-Ríos3, Noelia Rodríguez-Pérez2, Grissel Ríos2 and Luis M. Vilá2, 1School of Medicine, Ponce Health Sciences University, Ponce, PR, 2Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 3Puerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, PR

    Background/Purpose: Arterial vascular events have a great impact in the morbidity and mortality of rheumatoid arthritis (RA). Traditional and nontraditional risk factors for arterial vascular…
  • Abstract Number: 2677 • 2015 ACR/ARHP Annual Meeting

    Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in Patients with Rheumatoid Arthritis

    Ankita Satpute1, Stanley Hazen2,3, WH Wilson Tang3 and M. Elaine Husni4, 1Case Western Reserve University School of Medicine, Cleveland, OH, 2Cell Biology, Cell Biology, Cleveland Clinic Foundation, Cleveland, OH, 3Cardiology, Cardiology, Cleveland Clinic Foundation, Cleveland, OH, 4Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: Numerous studies have reported increased cardiovascular morbidity and mortality in rheumatoid arthritis (RA) patients that cannot be explained by traditional risk factors. In a…
  • Abstract Number: 1548 • 2015 ACR/ARHP Annual Meeting

    Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort

    Alberto Cardenas-de La Garza1, Raymundo Vera-Pineda2, Dionicio A. Galarza-Delgado1, Jose Ramon Azpiri-Lopez3, Iris J. Colunga-Pedraza1, Griselda Serna-Peña4 and Mario Alberto Garza-Elizondo1, 1Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 2Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 3Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 4Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico

    Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in RA. Management and stratification of ASCVD in RA patients is still a matter…
  • Abstract Number: 3257 • 2015 ACR/ARHP Annual Meeting

    The Link Between DAS28 and the Short-Term Risk of Acute Coronary Syndrome in RA, and Its Driving Factors

    Lotta Ljung1,2, Thomas Frisell3 and Johan Askling3,4, 1Department of Medicine, Solna, Clinical epidemiology unit, Karolinska Institutet, Stockholm, Sweden, 2Department for Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 3Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 4Rheumatology Unit, Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: The extent to which a short-term effect of the disease activity adds to the over-risk of coronary events in patients with Rheumatoid Arthritis (RA)…
  • Abstract Number: 1565 • 2015 ACR/ARHP Annual Meeting

    High Disease Activity over Time and Persistent Inflammation Are Associated with Increased Risk of Cardiovascular Disease in Patients with Early Rheumatoid Arthritis

    Emil Rydell1,2, Christina Book1,2, Jan-Åke Nilsson1,2, Minna Willim1,2, Lennart T.H. Jacobsson1,3 and Carl Turesson1,4, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 3Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden, 4Lund University, Rheumatology, Dept. of Clinical Sciences,, Malmö, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased rate of cardiovascular (CV) disease. Systemic inflammation has been implicated as a key factor behind CV…
  • Abstract Number: 1572 • 2015 ACR/ARHP Annual Meeting

    Plasma Apolipoprotein B48 Levels in Patients with Rheumatoid Arthritis: Evaluating Novel Cardiovascular Risk Factors

    Deborah van Breukelen-van der Stoep1, Derkjen van Zeben1, Marijke de Vries2, Boudewijn Klop2, Noelle van der Meulen2, Gert Jan van de Geijn3, Hans Janssen3, Pedro Valdivielso4, José Rioja4, José Ramirez-Bollero4, Mieke Hazes5, Erwin Birnie6,7 and Manuel Castro Cabezas8, 1Department of Rheumatology, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 2Department of Internal Medicine, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 3Department of Clinical Chemistry, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 4Department of Internal Medicine and Dermatology, Hospital Virgen de la Victoria, Malaga, Spain, 5Department of Rheumatology, Erasmus Medical Centre Rotterdam, Rotterdam, Netherlands, 6Statistics and Education, Sint Franciscus Gasthuis, Rotterdam, Netherlands, 7Insitute of Health Policy and Management, Erasmus University, Rotterdam, Netherlands, 8Department of Internal Medicine, Sint Francicscus Gasthuis, Rotterdam, Netherlands

    Background/Purpose: Chylomicrons, with apolipoprotein (apo) B48 as a structural protein, induce leukocyte and complement activation and contribute to atherosclerosis. ApoB48 is higher in conditions associated…
  • Abstract Number: 1575 • 2015 ACR/ARHP Annual Meeting

    Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with Rheumatoid Arthritis

    Ruth Davies1, Daniela Iacono2, Lauren A. Jordan1, Jessica O Williams1, Charlotte Rawlings1, Derek Lang3, Anwen S. Williams1 and Ernest H. Choy1, 1Cardiff University, Institute of Infection and Immunity, Tenovus Building, University Hospital of Wales, Cardiff, United Kingdom, 2Department of Clinical and Experimental Medicine. Rheumatology Section. Second University of Naples, Naples, Italy, 3Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom

    Background/Purpose:  Mortality is increased in Rheumatoid arthritis (RA) patients mainly due to cardiovascular (CV) disease; however the biologic mechanisms are unknown. Increased CV risk in…
  • Abstract Number: 1591 • 2015 ACR/ARHP Annual Meeting

    A Low Adiponectin Level in Rheumatoid Arthritis Is Associated with Coronary Artery Disease

    Jon Roger Eidet1, Ida G. Fostad2, Kelly J. Shields3, Torstein Lyberg1, Tor Paaske Utheim1, Anita Kåss4, Knut Mikkelsen5, Terje Veel6, Kjell Saatvedt7, Morten Wang Fagerland8, Matthew Liang9 and Ivana Hollan5, 1Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway, 2Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway, 3Medicine, Lupus Center of Excellence / Allegheny Health Network, Pittsburgh, PA, 4Rheumatology, Betanien Hospital, Skien, Norway, 5Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, 6Department of Cardiac Surgery, Feiring Heart Clinic, Feiring, Norway, 7Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway, 8Department of Biostatistics, Oslo University Hospital, Oslo, Norway, 9Department of Rheumatology, Brigham and Women’ s Hospital, Boston, Boston, MA

    Background/Purpose: Adipokines exert pleiotropic actions, including immunoregulatory and matrix degrading effects. There is evidence of adipokine involvement in the pathogenesis of cardiovascular (CV) disease as…
  • Abstract Number: 1592 • 2015 ACR/ARHP Annual Meeting

    Sex Differences in Cardiovascular Risk Factors and Event Rates in Patients with Rheumatoid Arthritis – Data from 13 Rheumatology Centers

    Silvia Rollefstad1, Eirik Ikdahl1, Cynthia S. Crowson2, Sherine Gabriel3, George D. Kitas4, Piet L van Riel5, Anne Grete Semb6 and ATACC-RA, 1Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Division of Rheumatology; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4The Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 5Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, Netherlands, 6Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular disease (CVD). There is a clear female to male preponderance of RA. In…
  • Abstract Number: 1593 • 2015 ACR/ARHP Annual Meeting

    Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis

    Michelle J. Ormseth1, Joseph F. Solus2, Annette M. Oeser3, Aihua Bian4, Tebeb Gebretsadik4, Ayumi Shintani5, Paolo Raggi6 and C Michael Stein5, 1Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, 2Clinical Pharmacology, Vanderbilt University, Nashville, TN, 3Medicine, Vanderbilt University, Nashville, TN, 4Biostatistics, Vanderbilt University, Nashville, TN, 5Vanderbilt University, Nashville, TN, 6Emory University, Atlanta, GA

    Background/Purpose: Telomeres protect against DNA damage and shorten with each cell division; their length may be a marker of cardiovascular and overall biological aging. Patients…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology